The Cancer Research & Treatment Fund (CR&T) is led by a Board of Directors that is supported by our Medical Advisory Board.  Together, they represent a broad cross-section of specialties and disciplines, working together to rapidly deploy funding to the frontlines of research and ensuring CR&T maintains its reputation as a leading voice in cancer research.

Thomas M. Silver, President

Executive Chairman, Bright Funds


Richard T. Silver, MD, Vice President, Medical Director

New York-Presbyterian/Weill Cornell Medicine


Joseph N. Aimi

President, Kenneth Bieber, Inc.


David T. Boule, Treasurer

Retired Partner, Ernst & Young


Maria Brisbane, CFA

Managing Director, Merrill Lynch


Keith Civil

Auburn Enlarged City School System (Retired)


Terry Hermanson

President, Mr. Christmas, Inc.


Michael C. Kempner

Managing General Partner, KS Capital Partners, LP


Kasia McCormick
Amanda Johns Perez
Jeffrey Puglisi, MD
Glenville Medical Concierge Care
Richard J. Rose

Sr. Managing Director, Retired, Shufro, Rose & Co., LLC


Todd J. Shaw

Senior Vice President, Morgan Stanley


Bharat Shah, PhD

Past President, Noble Investment Group (Retired)

AJ Shiekman

Strategy/Business Development Manager, Pure Storage


Adam Silver

Sr. Managing Member, Bennett Management


Tim Silver

Portfolio Manager, Empery Asset Management, LP


Anne Templeton


Nelson A. Boxer

Petrillo Klein & Boxer LLP